Helping hospitals reduce infection rates, sterilization robot manufacturer Xenex receives $38 million in financing

Release date: 2017-03-01

Helping hospitals eliminate bacteria that may cause nosocomial infections has always been a key part of government health care efforts. Many technology companies are also working on this, and Xenex Sterilization Services, a medical device manufacturer based in San Antonio, USA, is one of them. The robots it produces can effectively use pulsed æ°™ UV technology to purify the operating room and eliminate microorganisms hidden in medical equipment that may cause hospital-acquired infections.

On February 24th, Xenex announced a new round of $38 million in financing, led by Essex Woodlands (EW), the leading US healthcare private equity firm, and Piper Jaffray Commercial Bank, a new investor and existing investor, Malin And Tectonic Ventures continue to follow. This round of financing will be used to expand sales teams, product development, scientific research, and open up international markets. After this round of financing, the company's total financing has reached 94 million US dollars.

It is understood that nearly 300 cases in the United States die every day from infection during hospitalization. Internationally, the death toll may even be higher. Medically related infections (HAI) caused by microorganisms such as C. diff, methicillin-resistant Staphylococcus aureus (MRSA), and carbapenem-resistant Enterobacteriaceae (CRE) are global problems. Xenex's pulsed helium UV technology is a proven solution to quickly destroy these deadly factors before viruses, bacteria and spores pose a threat to patients and health care workers.

Xenex's LightStrike Germ-Zapping robot eliminates microscopic bacteria that may be missed in manual cleaning projects, helping hospitals reduce their HAI (hospital-associated infection) rates. The pulsed helium used by Xenex's sterilization robots is an environmentally friendly inert gas that creates a full spectrum of cells that can quickly destroy infectious bacteria in less than five minutes with high-intensity UV lamps.

Xenex CEO Morris Miller said that Xenex currently has more than 50 competitors selling UV equipment that uses mercury vapor lamps to produce ultraviolet light. Xenex is the only company that produces pulsed UV disinfection equipment. Unlike narrow-spectrum UV light produced by mercury bulbs, pulsed æ°™UV has been repeatedly proven to reduce infection rates and enhance patient safety. According to research published by hospitals that have used Xenex devices, C.diff, MRSA, and surgical site infection rates can be reduced by 50-100% when these hospitals use Xenex robots to disinfect rooms.

Designed according to the hospital environment, the Xenex robot is portable and easy to use, and does not interrupt the daily work of the hospital during use. Depending on the model of the robot, each disinfection takes approximately 4-5 minutes. Every day, the robot can disinfect 30-62 rooms including wards, operating rooms, equipment rooms, emergency rooms, intensive care units and public areas.

Xenex robots are currently being used in approximately 400 hospitals, Veterans Affairs and Defense Department facilities including the United States, Canada, Europe, Africa and Japan. These robots can also be used for the disinfection of care facilities, mobile surgery centers and long-term acute care facilities.

Source: 36æ°ª

Organic Scholartree Fruits Extracts

Organic Scholartree Fruits Extracts,Scholar Tree Fruit Extracts,Scholartree Fruits Extracts,Scholartree Extract

Hengshui Shanzhi Health Drink Co., Ltd , https://www.grasspowder-sz.com

Posted on